Basso Stephen — SEC insider filings
SEC reporting owner CIK 1815707. 15 insider filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2021-01-14 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Innoviva, Inc. (INVA) | Chief Financial Officer | 12 | — | — | 19 |
| Inozyme Pharma, Inc. (INZY) | SVP Finance (PFO) | 3 | — | — | 3 |
Insider filings — Basso Stephen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Innoviva, Inc. (INVA) | Tax withholding (F): 558 @ $21 | EDGAR |
| 2026-05-22 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 1,123 @ $0 · Tax withholding (F): 559 @ $22.24 | EDGAR |
| 2026-05-06 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 37,994 @ $0 · Grant/award (A): 93,750 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Innoviva, Inc. (INVA) | Tax withholding (F): 1,244 @ $23.39 | EDGAR |
| 2025-11-24 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 604 @ $0 · Tax withholding (F): 237 @ $21.16 | EDGAR |
| 2025-11-05 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 27,609 @ $18.11 | EDGAR |
| 2025-08-22 | 4 | Innoviva, Inc. (INVA) | Tax withholding (F): 237 @ $19.95 | EDGAR |
| 2025-05-22 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 1,353 @ $0 · Tax withholding (F): 237 @ $18.78 | EDGAR |
| 2025-03-26 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 10,569 @ $18.08 · Grant/award (A): 100,831 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 843 @ $0 · Tax withholding (F): 1,106 @ $18.07 | EDGAR |
| 2024-03-07 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 12,096 @ $14.88 · Grant/award (A): 25,899 (derivative) @ $0 | EDGAR |
| 2023-08-31 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-03-25 | 4 | Inozyme Pharma, Inc. (INZY) | Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2021-03-17 | 4 | Inozyme Pharma, Inc. (INZY) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2021-01-14 | 4 | Inozyme Pharma, Inc. (INZY) | Grant/award (A): 41,794 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1815707 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs